The Study That Scared a Generation Off HRT (And Why It Was Wrong)

Key Takeaways

• ✦The Women's Health Initiative study that linked HRT to breast cancer had significant methodological problems — including enrolling women who were, on average, 63 years old and over a decade past menopause onset, making its findings poorly applicable to perimenopausal women seeking symptom relief.
• ✦Current evidence suggests the breast cancer risk from combined estrogen-progestogen HRT, when initiated in women close to menopause onset, is small — roughly comparable to the risk associated with drinking one to two glasses of wine per night or being overweight.
• ✦A NAMS-published study found that postmenopausal Korean women with type 2 diabetes reported significantly more numerous and more severe menopause symptoms than women without T2DM, suggesting metabolic health and hormonal symptom burden are meaningfully connected.
• ✦A randomized controlled trial published in Menopause found a specific probiotic formula associated with improvements in menopause-related symptoms and quality of life — but the global symptom score between groups wasn't statistically different, and researchers say more studies are needed before drawing firm conclusions.
• ✦The probiotic finding matters less as a "take this supplement" message and more as a signal that the gut-hormone axis may be a real and underexplored area of menopause research.